Hercules Capital Reports Second Quarter 2026 Financial Results Record 1H 2026 Total New Debt and Equity Commitments of $2.74 Billion, an Increase of 35.6% Year-over-Year Record 1H 2026 Total Fundings of $1.35 Billion, an Increase of 8.5%…
Hercules Capital Reports Second Quarter 2026
Financial Results
Record 1H 2026 Total New Debt and Equity Commitments of $2.74 Billion, an Increase of 35.6%
Year-over-Year
Record 1H 2026 Total Fundings of $1.35 Billion, an Increase of 8.5% Year-over-Year
Record 1H 2026 Total Investment Income of $290.7 Million, an Increase of 13.1% Year-overYear
Record 1H 2026 Net Investment Income "NII" of $181.0 Million, an Increase of 8.9% Year-overYear
Record Q2 2026 Total Investment Income of $149.1 Million, an Increase of 8.5% Year-over-Year
Record Q2 2026 NII of $92.9 Million, an Increase of 4.7% Year-over-Year
Q2 2026 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution
Conservative Balance Sheet Management with Net GAAP Leverage of 101.8% and Net
Regulatory Leverage of 86.4%
Inclusive of the Adviser Funds Advised by Hercules Adviser LLC, its Wholly-Owned Subsidiary,
Hercules had over $1.0 Billion of Available Liquidity as of the end of Q2 2026
Undistributed Earnings Spillover of $171.7 Million, or $0.92(1) per Ending Shares Outstanding
Approximately $6.1 Billion of Assets Under Management, an Increase of 14.4% Year-over-Year(2)
Q2 2026 Financial Achievements and Highlights
•
Record Total Investment Income of $149.1 million, an increase of 8.5% year-over-year
•
Record NII of $92.9 million, or $0.50 per share, an increase of 4.7% year-over-year
•
Total new debt and equity commitments of $927.3 million
•
•
Total fundings of $647.5 million
•
•
Net Hercules debt and equity commitments of $707.1 million(3)
Net Hercules fundings of $459.1 million(3)
Unscheduled early principal repayments or “early loan repayments” of $572.1 million, an
increase of 153.4% from $225.8 million in Q1 2026
•
$652.9 million of available liquidity, subject to existing terms and covenants
1
•
16.8% Return on Average Equity “ROAE” (NII/Average Equity)(4)
•
8.3% Return on Average Assets “ROAA” (NII/Average Assets)
•
GAAP leverage of 103.9% and regulatory leverage of 88.5%(5)
•
Net GAAP leverage (includes SBA debentures and excludes cash) of 101.8% and
net regulatory leverage (excludes SBA debentures and cash) of 86.4%
•
Net Asset Value “NAV” of $12.15 per share, an increase of 2.1% from Q1 2026
•
13.4% GAAP Effective Yield and 12.0% Core Yield(6), a non-GAAP measure
Six months ending June 30, 2026 Financial Highlights
•
Record 1H 2026 Total Investment Income of $290.7 million, an increase of 13.1% yearover-year
•
Record 1H 2026 NII of $181.0 million, an increase of 8.9% year-over-year
•
Record 1H 2026 total new debt and equity commitments of $2.74 billion, an increase of
35.6% year-over-year
• Record 1H 2026 total fundings of $1.35 billion, an increase of 8.5% year-over-year
• 1H 2026 net debt investment portfolio growth of $127.8 million
• Unscheduled early loan repayments of $797.9 million
Footnotes:
(1)
(2)
(3)
(4)
(5)
(6)
$0.93 per Weighted Average Shares Outstanding
Assets under management includes assets managed by Hercules Capital, Inc. ("Hercules") and the Adviser Subsidiary (defined below)
Net Hercules commitments and fundings are net of what was assigned to or directly committed or funded by the "Adviser Funds" which are external vehicles advised by
Hercules Adviser LLC (the “Adviser Subsidiary")” during the quarter
As presented above, ROAE is (i) sourced from Hercules as of June 30, 2026 and (ii) based on NII, excluding realized and unrealized gains/losses
Regulatory leverage represents debt-to-equity ratio, excluding the Company’s Small Business Administration (“SBA”) debentures
Core Yield excludes early loan repayments, dividends from the Adviser Subsidiary, one-time fees and bank interest income, and includes income and fees from expired
commitments
SAN MATEO, Calif., July 30, 2026 – Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” "Hercules
Capital," or the “Company”), the largest and leading specialty financing provider to innovative
venture, growth and established stage companies backed by some of the leading and top-tier
venture capital and select private equity firms, today announced its financial results for the second
quarter ended June 30, 2026.
"Following record-breaking originations in Q1 2026, the Hercules platform continued to see strong
deal flow in Q2 and delivered new originations of $927.3 million and fundings of $647.5 million,"
stated Scott Bluestein, chief executive officer and chief investment officer of Hercules. “We
delivered record originations of $2.74 billion and record fundings of $1.35 billion for the first half
of 2026, an increase of 35.6% and 8.5% year-over-year, respectively."
Bluestein added, “The strong new business activity in the first half of 2026 combined with
continued stable credit performance drove new financial records for both total investment income
and net investments income. Operating at these levels, we continue to comfortably cover our base
dividend with 125% coverage for Q2."
Bluestein concluded, "We remain focused on continuing to manage our business and balance sheet
conservatively and are confident in the strength of the Hercules platform and our ability to
generate strong operating results irrespective of market dynamics. We believe our platform's
scale, balance sheet and liquidity will continue to position us well throughout the remainder of the
year."
2
Q2 2026 Review and Operating Results
Debt Investment Portfolio
Hercules delivered Q2 new debt and equity commitments totaling $927.3 million and Q2 new
fundings totaling $647.5 million.
During the second quarter, Hercules realized early loan repayments of $572.1 million which, along
with normal scheduled amortization of $43.7 million, resulted in total debt repayments of $615.8
million.
The new debt investment origination and funding activities combined with repayments and normal
scheduled amortization led to a net debt investment portfolio decrease of $170.2 million during
the second quarter on a cost basis.
The Company’s total investment portfolio, (at cost and fair value) by category, quarterover-quarter is highlighted below:
Total Investment Portfolio: Q1 2026 to Q2 2026
Equity & Other
(in millions)
Balances at Cost at March 31, 2026
New fundings
Debt
$
(a)
Investments
4,561.9
$
Warrants
174.1
$
Total Portfolio
34.4
$
4,770.4
637.2
6.6
3.7
647.5
Fundings assigned to or directly funded by Adviser Funds
(185.4)
(1.8)
(1.2)
(188.4)
Principal payments received on investments
(43.7)
—
—
(43.7)
(572.1)
—
—
(572.1)
(16.6)
—
—
(16.6)
10.4
(2.6)
(1.6)
6.2
(170.2)
2.2
0.9
(167.1)
Early payoffs
(b)
Assets Sale - Participants
Net changes attributed to conversions, liquidations, and fees
Net activity during Q2 2026
Balances at Cost at June 30, 2026
$
4,391.7
$
176.3
$
35.3
$
4,603.3
Balances at Fair Value at March 31, 2026
$
4,540.1
$
139.4
$
42.5
$
4,722.0
Net activity during Q2 2026
(170.2)
2.2
0.9
(167.1)
Net change in unrealized appreciation (depreciation)
7.1
14.8
7.9
29.8
FX unrealized gain (loss)
(0.8)
—
—
(0.8)
Total net activity during Q2 2026
Balances at Fair Value at June 30, 2026
(163.9)
$
4,376.2
(a) Includes $2.6 million fundings associated with revolver loans during Q2 2026.
(b) Early payoffs includes $7.5 million paydowns on revolvers during Q2 2026.
3
17.0
$
156.4
8.8
$
51.3
(138.1)
$
4,583.9
Debt Investment Portfolio Balances by Quarter
(in millions)
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Ending Balance at Cost
$4,391.7
$4,561.9
$4,263.9
$4,073.2
$3,977.3
Weighted Average Balance
$4,397.1
$4,397.8
$4,148.1
$3,970.0
$3,884.1
Debt Investment Portfolio Composition by Quarter
(% of debt investment portfolio)
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
First Lien Senior Secured
86.8%
88.6%
89.3%
90.4%
91.0%
Floating Rate w/Floors
97.8%
98.0%
97.9%
97.8%
97.8%
GAAP Effective Portfolio Yield and Core Portfolio Yield (“Core Yield”)
The GAAP effective yield on Hercules’ debt investment portfolio was 13.4% during Q2 2026 as
compared to 12.8% for Q1 2026. The Company realized $572.1 million of early loan repayments
in Q2 2026 compared to $225.8 million in Q1 2026, or an increase of 153.4%. Effective yields
generally include the effects of fees and income accelerations attributed to early loan repayments
and other one-time events. Effective yields are materially impacted by the elevated or reduced
levels of early loan repayments and derived by dividing total investment income by the weighted
average earning investment portfolio assets outstanding during the quarter, which excludes noninterest earning assets such as warrants and equity investments.
Core Yield, a non-GAAP measure, was 12.0% during Q2 2026, within the Company’s expected
range of 12.0% to 12.5%, and decreased from 12.2% in Q1 2026. Hercules defines Core Yield as
yield that generally excludes any benefit from income related to early repayments attributed to
the acceleration of unamortized income and prepayment fees and includes income from expired
commitments.
Income Statement
Total investment income increased to $149.1 million for Q2 2026, compared to $137.5 million in
Q2 2025. The increase is primarily attributable to a higher weighted average debt investment
portfolio between periods.
Non-interest and fee expenses were $30.0 million in Q2 2026, compared to $26.5 million in Q2
2025. The increase was primarily due to an increase in variable employee compensation expenses
and tax expenses.
Interest expense and fees were $31.1 million in Q2 2026, compared to $25.7 million in Q2 2025.
The increase was primarily due to higher weighted average borrowings and higher utilization of
the credit facilities.
The Company had a weighted average cost of borrowings comprised of interest and fees, of 5.2%
in Q2 2026, as compared to 5.0% for Q2 2025.
4
NII – Net Investment Income
NII for Q2 2026 was $92.9 million, or $0.50 per share, based on 185.5 million basic weighted
average shares outstanding, compared to $88.7 million, or $0.50 per share, based on 176.8 million
basic weighted average shares outstanding in Q2 2025. The increase in NII is primarily attributable
to an increase in total investment income due to a higher weighted average debt investment
portfolio offset by higher interest expense and higher variable employee compensation benefits
between periods.
Continued Credit Discipline and Strong Credit Performance
Hercules’ net cumulative realized gain/(loss) position, since its first origination activities in October
2004 through June 30, 2026, (including net loan, warrant and equity activity and excluding loss
on debt extinguishment, foreign exchange movements and other non-credit related losses) on
investments totaled ($107.4) million, on a GAAP basis, spanning more than 21 years of investment
activities.
When compared to total net new debt investment commitments during the same period of
approximately $24.3 billion, the total realized gain/(loss) since inception of ($107.4) million
represents approximately 44 basis points (“bps”), or 0.44%, of cumulative debt commitments, or
an effective annualized loss rate of 2.0 bps, or 0.020%.
Realized Gains/(Losses)
During Q2 2026, Hercules had net realized gains of $7.7 million primarily due to gains on equity
investments.
Unrealized Appreciation/(Depreciation)
During Q2 2026, Hercules recorded $29.6 million of net unrealized appreciation, net of the impact
of foreign currency movements. This is primarily attributable to $16.3 million of net unrealized
appreciation attributable to valuation movements in publicly and privately held equity and
investment funds, $13.4 million of net unrealized appreciation attributable to debt investments,
and $10.7 million of net unrealized appreciation attributable to valuation movements in publicly
and privately held warrants. This was partially offset by ($10.6) million of reversals of previous
quarter appreciation upon a realization event and ($0.2) million of net unrealized depreciation
attributable to net foreign exchange movements.
Portfolio Asset Quality
As of June 30, 2026, the weighted average grade of the debt investment portfolio, at cost, was
2.17 compared to 2.11 as of March 31, 2026, based on a scale of 1 to 5, with 1 being the highest
quality. Hercules’ policy is to generally adjust the credit grading down on its portfolio companies
as they approach their expected need for additional growth equity capital to fund their respective
operations for the next 9-14 months. Various portfolio companies in the Company’s portfolio will
require additional rounds of funding from time to time to maintain their operations. Additionally,
Hercules may selectively downgrade portfolio companies from time to time if they are not meeting
the Company’s financing criteria or are underperforming relative to their respective business plans.
5
As of June 30, 2026, grading of the debt investment portfolio at fair value, excluding warrants and
equity investments, was as follows:
Credit Grading (at Fair Value), Q2 2026 - Q2 2025 ($ in millions)
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
940.5
944.5
681.6
513.4
617.2
15.5%
Grade 1 - High
$
Grade 2
$ 1,920.8
43.9% $ 2,256.5
49.7% $ 2,169.0
50.7% $ 2,128.9
52.0% $ 1,886.3
47.4%
Grade 3
$ 1,432.5
32.7% $ 1,300.0
28.6% $ 1,355.5
31.7% $ 1,340.9
32.7% $ 1,381.0
34.7%
Grade 4
$
76.9
1.8% $
35.4
0.8% $
73.3
1.7% $
112.4
2.8% $
94.2
2.4%
Grade 5 - Low
$
5.5
0.1% $
3.7
0.1% $
—
—% $
—
—% $
—
—%
Weighted Avg.
(at Cost)
21.5% $
2.17
20.8% $
2.11
15.9% $
2.20
12.5% $
2.27
2.26
Non-Accruals
The number of loans on non-accrual increased quarter-over-quarter. As of June 30, 2026, the
Company had two debt investments on non-accrual with an investment cost and fair value of
approximately $16.0 million and $5.5 million, respectively, or 0.3% and 0.1% as a percentage of
the Company’s total investment portfolio at cost and value, respectively.
As of March 31, 2026, the Company had one debt investment on non-accrual with an investment
cost and fair value of approximately $10.7 million and $3.7 million, respectively, or 0.2% and
0.1% as a percentage of the Company’s total investment portfolio at cost and value, respectively.
Total Investments at Cost
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
$4,603.3
$4,770.4
$4,467.8
$4,290.8
$4,192.5
0.1%
0.1%
0.1%
1.1%
0.2%
0.3%
0.2%
0.2%
1.2%
0.2%
Loans on non-accrual as a % of Total
Investments at Value
Loans on non-accrual as a % of Total
Investments at Cost
Liquidity and Capital Resources
The Company ended Q2 2026 with $652.9 million in available liquidity, including $48.2 million in
unrestricted cash and cash equivalents, and $604.7 million available under its credit facilities,
subject to existing terms, advance rates, regulatory and covenant requirements.
In addition to the Company's available liquidity, it has 15.3 million shares remaining available for
issuance and sale under the equity ATM program.
Credit Facilities
As of June 30, 2026, there were $88.0 million outstanding borrowings under Hercules’ $440.0
million committed credit facility with MUFG Bank, Ltd. and $221.7 million of outstanding
borrowings and $0.5 million of outstanding letter of credits under Hercules’ $475.0 million
committed credit facility and letter of credit facility with SMBC.
6
Leverage
As of June 30, 2026, Hercules’ GAAP leverage ratio, including its SBA debentures, was 103.9%.
Hercules’ regulatory leverage, or debt-to-equity ratio, excluding its SBA debentures, was 88.5%
and net regulatory leverage, a non-GAAP measure (excluding cash of approximately $48.2
million), was 86.4%. Hercules’ net leverage ratio, a non-GAAP measure (including its SBA
debentures), was 101.8%.
Available Unfunded Commitments – Representing 8.7% of Total Assets
The Company’s unfunded commitments and contingencies consist primarily of unused
commitments to extend credit in the form of loans to select portfolio companies. A portion of these
unfunded contractual commitments are dependent upon the portfolio company reaching certain
milestones in order to gain access to additional funding. Furthermore, the credit agreements the
Company enters into with its portfolio companies contain customary lending provisions that allow
us relief from funding obligations for previously made commitments in instances where the
underlying company experiences materially adverse events that affect the financial condition or
business outlook for the portfolio company. In addition, since a portion of these commitments may
also expire without being drawn, unfunded contractual commitments do not necessarily represent
future cash requirements.
As of June 30, 2026, the Company had $408.2 million of available unfunded commitments at the
request of the portfolio company and unencumbered by any milestones, including undrawn
revolving facilities, representing 8.7% of Hercules’ total assets. The amount of available unfunded
commitments increased from the previous quarter of $397.4 million or 8.2% of Hercules’ total
assets.
Existing Pipeline and Signed Term Sheets
After closing $927.3 million in new debt and equity commitments in Q2 2026, Hercules has pending
commitments of $70.0 million in signed non-binding term sheets outstanding as of July 27, 2026.
Since the close of Q2 2026 and as of July 27, 2026, Hercules has closed new debt and equity
commitments (before assignments to or direct originations by the Adviser Funds) of $149.3 million
and funded $112.5 million.
Signed non-binding term sheets are subject to satisfactory completion of Hercules’ due diligence
and final investment committee approval process as well as negotiations of definitive
documentation with the prospective portfolio companies. These non-binding term sheets generally
convert to contractual commitments in approximately 90 days from signing and some portion may
be assigned or allocated to or directly originated by private funds managed by the Adviser
Subsidiary prior to or after closing.
7
The table below summarizes the Company’s year-to-date closed and pending commitments:
Closed Commitments and Pending Commitments (in millions)
January 1 - June 30, 2026 Closed Commitments (a)(c)
$2,739.5
$149.3
$2,888.8
$70.0
$2,958.8
Q3 2026 Closed Commitments (as of July 27, 2026)
Year-to-Date 2026 Closed Commitments (as of July 27, 2026)(a)(c)
(a)(c)
Q3 2026 Pending Commitments (as of July 27, 2026)(b)
Year-to-Date 2026 Closed and Pending Commitments (a)(b)(c)
Notes:
a.
b.
c.
Closed commitments may include renewals of existing credit facilities and equity commitments. Not all closed commitments result in future cash requirements.
Commitments generally fund over the two succeeding quarters from close.
Not all pending commitments (signed non-binding term sheets) are expected to close and do not necessarily represent any future cash requirements.
Gross commitments before assignments to or direct originations by the Adviser Funds.
Net Asset Value
As of June 30, 2026, the Company’s net assets were $2.3 billion, compared to $2.2 billion at the
end of Q1 2026. NAV per share increased 2.1% to $12.15 on 187.2 million outstanding shares of
common stock as of June 30, 2026, compared to $11.90 on 187.2 million outstanding shares of
common stock as of March 31, 2026. The increase in NAV per share was primarily attributed to
the unrealized appreciation on our debt, warrant and equity investment portfolio.
Interest Rate Sensitivity
Hercules has an asset sensitive debt investment portfolio with 97.8% of its debt investment
portfolio being priced at floating interest rates as of June 30, 2026, with a Prime or Non-Prime
based (SOFR) interest rate floor, combined with 86.9% of its outstanding debt borrowings bearing
fixed interest rates, leading to higher net investment income sensitivity.
Based on Hercules’ Consolidated Statement of Assets and Liabilities as of June 30, 2026, the
following table shows the approximate annualized increase/(decrease) in components of net
income resulting from operations of hypothetical base rate changes in interest rates, such as Prime
Rate, assuming no changes in Hercules’ debt investments and borrowings. These estimates are
subject to change due to the impact from active participation in the Company’s equity ATM program
and any future equity offerings.
(in thousands)
Basis Point Change
Interest Income(1)
Interest
Net
Expense
Income
EPS(2)
(200)
$
(17,420) $
(6,891) $
(10,529) $
(0.06)
(100)
$
(10,697) $
(3,446) $
(7,251) $
(0.04)
(75)
$
(8,969) $
(2,584) $
(6,385) $
(0.03)
(50)
$
(6,434) $
(1,723) $
(4,711) $
(0.03)
(25)
$
(3,838) $
(861) $
(2,977) $
(0.02)
25
$
5,357
$
861
$
4,496
$
0.02
50
$
12,000
$
1,723
$
10,277
$
0.06
75
$
18,725
$
2,584
$
16,141
$
0.09
(1) Source; Hercules Form 10-Q for Q2 2026
(2) Earnings per share calculated on basic weighted shares outstanding of 185,517. Estimates are subject to change due to impact from active participation in the Company's
equity ATM program and any future equity offerings.
8
Existing Equity and Warrant Portfolio
Equity Portfolio
Hercules held equity positions in 73 portfolio companies with a fair value of $149.3 million and a
cost basis of $171.3 million as of June 30, 2026. On a fair value basis, 21.2% or $33.1 million is
related to public equity positions.
Warrant Portfolio
Hercules held warrant positions in 117 portfolio companies with a fair value of $51.3 million and a
cost basis of $35.3 million as of June 30, 2026. On a fair value basis, 25.7% or $13.2 million is
related to public warrant positions.
Portfolio Company IPO and M&A Activity in Q2 2026 and QTD Q3 2026
As of July 27, 2026, Hercules held debt, warrant or equity positions in seven (7) portfolio
companies that have completed or announced an IPO or M&A event, including:
IPO and SPAC Activity as of Q2 2026 and QTD Q3 2026
• In May 2026, Hercules portfolio company HawkEye 360 (NYSE: HAWK), a geospatial
analytics company that operates a first-of-its-kind commercial satellite constellation to
detect, characterize, and geolocate Radio Frequency (RF) signals from space, completed its
IPO of its common stock. Hercules initially committed $13.1 million in venture debt financing
beginning in December 2025 and currently holds warrants for 40,912 shares of common
stock as of June 30, 2026.
M&A Activity in Q2 2026 and QTD Q3 2026
• In May 2026, Hercules’ portfolio company PathAI, a privately held company in digital
pathology and AI-powered technology for pathology laboratories and the biopharma
industry, announced it has entered into a definitive merger agreement to be acquired by
Roche (OTCQX: RHHBY), a healthcare company placed to prevent, stop and cure diseases
by uniting leading science and technology across diagnostics, medicines and digital
solutions, for $750.0 million. The acquisition is subject to customary closing conditions and
regulatory approvals. Hercules committed $75.0 million in venture debt financing beginning
in December 2022 and currently holds warrants for 53,418 shares of common stock, as of
June 30, 2026.
• In May 2026, Hercules’ portfolio company Curevo, Inc., a clinical-stage biotechnology
company focused on bringing new generation adjuvanted subunit vaccines to market,
entered into a definitive agreement to be acquired by Eli Lilly (NYSE: LLY), a medicine
company turning science into healing to make life better for people around the world, for
up to $1.5 billion in cash. The acquisition is subject to customary regulatory approvals and
closing conditions. Hercules committed $27.5 million in June 2023 and currently holds
warrants for 95,221 shares of common stock, as of June 30, 2026.
9
•
In June 2026, Hercules’ portfolio company Contentful Global, Inc., a leading composable
content platform trusted by over 4,800 of the world’s leading brands to deliver personalized
digital experiences at scale, entered into a definitive agreement to be acquired by
Salesforce, Inc. (NYSE: CRM), the global leader in CRM. Terms of the acquisition were not
disclosed. The acquisition is subject to customary regulatory approvals and closing
conditions. Hercules committed $15.0 million in June 2018 and currently holds 41,000
shares of Preferred Series C stock and 108,500 shares of Preferred Series D stock, as of
June 30, 2026.
•
In June 2026, Hercules’ portfolio company SUNation Energy, Inc. (NASDAQ: SUNE), a
leading provider of residential and commercial solar energy systems, entered into a
definitive reverse merger agreement with Suniva, the largest and oldest U.S. merchant
manufacturer of high-efficiency monocrystalline silicon solar cells. Suniva will merge with
a wholly-owned subsidiary of SUNation, and the combined company is expected to operate
under the Suniva name and continue SUNation’s listing on the Nasdaq Capital Market. Upon
closing, pre-merger SUNation stockholders are expected to own equity with an implied value
of approximately $2.26 per share. The acquisition is subject to customary regulatory
approvals and closing conditions. Hercules initially committed $7.9 million in December
2020 and currently holds 3 shares of common stock, as of June 30, 2026.
•
In June 2026, Hercules’ portfolio company Fin (formerly Intercom, Inc.), an industryleading customer agent company, entered into a definitive agreement to be acquired by
Salesforce, Inc. (NYSE: CRM), the global leader in CRM, for approximately $3.6 billion. The
acquisition is subject to customary regulatory approvals and closing conditions. Hercules
committed $250.0 million in March 2026.
•
In June 2026, Hercules’ portfolio company Dragos, Inc., the global leader in cybersecurity
for operational technology environments, entered into an agreement to have a majority
stake of the company acquired by Accenture (NYSE: ACN), a global professional services
and technology consulting company that helps large organizations reinvent themselves
using digital technologies, cloud and AI. Terms of the majority stake acquisition were not
disclosed. Hercules committed $60.0 million in June 2023 and currently holds warrants for
57,528 shares of common stock, as of June 30, 2026.
There can be no assurances that companies that have yet to complete their IPOs will do so or that
pending merger announcements will close.
Subsequent Events
On July 24, 2026, the Company issued $325.0 million in aggregate principal amount of 6.300%
interest-bearing unsecured notes due July 24, 2031 (the “July 2031 Notes”), unless repurchased
in accordance with the terms of the Eleventh Supplemental Indenture, dated July 24, 2026 (the
“Eleventh Supplemental Indenture”). Interest on the July 2031 Notes is payable semiannually in
arrears on January 24 and July 24 of each year, commencing January 24, 2027. The July 2031
Notes are general unsecured obligations and rank pari passu, or equally in right of payment, with
all outstanding and future unsecured unsubordinated indebtedness issued by the Company. The
Company may redeem some or all of the July 2031 Notes at any time, or from time to time, at
the redemption price set forth under the terms of the Eleventh Supplemental Indenture.
10
Non-GAAP Financial Measures
To provide additional information about the Company’s results, the Company’s management has
discussed in this press release the Company’s Core Yield (calculated as yield excluding early loan
repayments, dividends from the Adviser Subsidiary, one-time fees and bank interest income, and
includes income and fees from expired commitments), core investment income (calculated as total
investment income from debt investments excluding fees and other income accelerations
attributed to early payoffs, deal restructuring, loan modifications, and other one-time income
events, but includes income from expired commitments), net leverage ratio (calculated as net
debt (i.e., debt less unrestricted cash) divided by total net assets), and its net regulatory leverage
(calculated as net debt (i.e., debt less unrestricted cash), excluding SBA debentures, divided by
total net assets), which are not prepared in accordance with GAAP. These non-GAAP measures are
included to supplement the Company’s financial information presented in accordance with GAAP
and because the Company uses such measures to monitor and evaluate its leverage and financial
condition and believes the presentation of these measures enhances investors’ ability to analyze
trends in the Company’s business and to evaluate the Company’s leverage and ability to take on
additional debt. However, these non-GAAP measures have limitations and should not be considered
in isolation or as a substitute for analysis of the Company’s financial results as reported under
GAAP.
These non-GAAP measures are not in accordance with, or an alternative to, measures prepared in
accordance with GAAP and may be different from non-GAAP measures used by other companies.
In addition, these non-GAAP measures are not based on any comprehensive set of accounting
rules or principles. These measures should only be used to evaluate the Company’s results of
operations in conjunction with their corresponding GAAP measures.
Conference Call
Hercules has scheduled its second quarter 2026 financial results conference call for July 30, 2026
at 2:00 p.m. PT (5:00 p.m. ET). All interested parties are invited to participate via telephone or
the live webcast, which will be hosted on a webcast link located on the Investor Resources section
of our website at investor.htgc.com. Please visit the website to test your connection before the
webcast. Domestic callers can access the conference call toll free by dialing +1 (800) 267-6316.
International callers can access the conference call by dialing +1 (203) 518-9783. All callers are
asked to dial in 10-15 minutes prior to the call so that name and company information can be
collected and to reference the conference ID HTGCQ226. For interested parties, an archived replay
will be available on a webcast link located on the Investor Resources section of Hercules Capital's
website.
About Hercules Capital, Inc.
Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused
on providing senior secured venture growth loans to high-growth, innovative venture capitalbacked companies in a broad variety of technology and life sciences industries. Since inception
(December 2003), Hercules has committed more than $28 billion to over 700 companies and is
the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing.
Companies interested in learning more about financing opportunities should contact
[email protected], or call 650.289.3060.
Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC, also maintains an
asset management business through which it manages investments for external parties (“Adviser
Funds”). The Adviser Subsidiary is registered as an investment adviser under the Investment
Advisers Act of 1940.
11
Hercules’ common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol
“HTGC.” In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE:
HCXY).
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. We may use words such as “anticipates,” “believes,”
“expects,” “intends,” “will,” “should,” “may” and similar expressions to identify forward-looking
statements. Forward-looking statements are not guarantees of future performance and should not
be relied upon in making any investment decision. Such statements are based on currently
available operating, financial and competitive information and are subject to various risks and
uncertainties that could cause actual results to differ materially from our historical experience and
our present expectations. While we cannot identify all such risks and uncertainties, we urge you
to read the risks discussed in our Annual Report on Form 10-K and other materials that we publicly
file with the Securities and Exchange Commission. Any forward-looking statements made in this
press release are made only as of the date hereof. Hercules assumes no obligation to update any
such statements in the future.